ANNUNZIATA, PASQUALE
 Distribuzione geografica
Continente #
NA - Nord America 12.923
EU - Europa 8.736
AS - Asia 4.118
SA - Sud America 674
AF - Africa 134
Continente sconosciuto - Info sul continente non disponibili 105
OC - Oceania 29
Totale 26.719
Nazione #
US - Stati Uniti d'America 12.786
GB - Regno Unito 1.920
IT - Italia 1.744
CN - Cina 1.671
SG - Singapore 1.187
RU - Federazione Russa 1.163
IE - Irlanda 859
DE - Germania 822
UA - Ucraina 709
BR - Brasile 543
SE - Svezia 528
FR - Francia 486
HK - Hong Kong 318
VN - Vietnam 291
KR - Corea 225
FI - Finlandia 183
ES - Italia 133
IN - India 83
BD - Bangladesh 76
CA - Canada 66
ZA - Sudafrica 61
TR - Turchia 60
NL - Olanda 52
AR - Argentina 38
MX - Messico 38
JP - Giappone 34
PK - Pakistan 28
BE - Belgio 25
IQ - Iraq 25
EC - Ecuador 22
AU - Australia 21
CO - Colombia 21
VE - Venezuela 20
NG - Nigeria 17
PL - Polonia 16
ID - Indonesia 14
CI - Costa d'Avorio 11
RO - Romania 11
SA - Arabia Saudita 11
AT - Austria 10
CL - Cile 10
CZ - Repubblica Ceca 9
EG - Egitto 9
UZ - Uzbekistan 9
IL - Israele 8
MA - Marocco 8
MY - Malesia 8
NZ - Nuova Zelanda 8
AE - Emirati Arabi Uniti 7
DK - Danimarca 7
EU - Europa 7
JO - Giordania 7
PY - Paraguay 7
AZ - Azerbaigian 6
CH - Svizzera 6
KE - Kenya 6
NP - Nepal 6
RS - Serbia 6
AL - Albania 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EE - Estonia 5
GR - Grecia 5
PH - Filippine 5
TN - Tunisia 5
UY - Uruguay 5
BO - Bolivia 4
BY - Bielorussia 4
CR - Costa Rica 4
HR - Croazia 4
HU - Ungheria 4
JM - Giamaica 4
KG - Kirghizistan 4
LB - Libano 4
LT - Lituania 4
PR - Porto Rico 4
BB - Barbados 3
BH - Bahrain 3
ET - Etiopia 3
HN - Honduras 3
IR - Iran 3
KZ - Kazakistan 3
NI - Nicaragua 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
AM - Armenia 2
CY - Cipro 2
IM - Isola di Man 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AO - Angola 1
Totale 26.598
Città #
Menlo Park 2.982
Southend 1.721
Fairfield 1.016
Dallas 1.000
Dublin 856
Ashburn 785
Singapore 623
Jacksonville 564
Chandler 553
Woodbridge 476
Santa Clara 472
Milan 435
Beijing 424
Wilmington 414
Seattle 393
Ann Arbor 375
Houston 360
Cambridge 326
San Jose 324
Hong Kong 305
Moscow 297
Hefei 278
Seoul 224
Council Bluffs 193
Nanjing 187
Rome 172
Princeton 162
The Dalles 139
Los Angeles 113
Málaga 107
Lauterbourg 101
Siena 97
Boardman 90
Ho Chi Minh City 85
Hanoi 82
Nanchang 80
Dearborn 77
New York 76
San Diego 70
Helsinki 68
Buffalo 66
Johannesburg 50
São Paulo 42
Columbus 41
Turin 41
Izmir 40
San Mateo 40
Kunming 39
Norwalk 39
Florence 38
London 38
Shenyang 38
Hebei 35
San Francisco 35
Tianjin 32
Naples 29
Bologna 28
Tokyo 27
Bengaluru 25
Jiaxing 25
Changsha 23
Munich 23
Shanghai 23
Brussels 22
Chicago 22
Rio de Janeiro 22
Atlanta 21
Jinan 20
Orem 20
Palermo 20
Toronto 20
Düsseldorf 19
Venezia 18
Phoenix 17
Redondo Beach 17
Figino 16
Philadelphia 16
Abuja 15
Ottawa 15
Bari 14
Dhaka 14
Genoa 14
Brasília 13
Chennai 13
Guangzhou 13
Hangzhou 13
Padua 13
Baghdad 12
Zhengzhou 12
Abidjan 11
Amsterdam 11
Brooklyn 11
Curitiba 11
Haiphong 11
Madrid 11
Nuremberg 11
Redwood City 11
Stockholm 11
Boston 10
Denver 10
Totale 18.469
Nome #
Meningoencefalite da Listeria e sindrome di Miller-Fisher: un’inusuale associazione 778
Sclerosi multipla e sindrome di Sjogren . Più di una semplice associazione? 730
A case of bilateral facial palsy with detection of herpes simplex virus type 1 DNA in the cerebrospinal fluid and serum anti-gm1 antibodies 380
Listeria meningoencephalitis and anti-GQ1b antibody syndrome 353
Altered CSF protein pattern in a case of mycosis fungoides with nervous system involvement 348
Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome 321
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 320
Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing-remitting multiple sclerosis 316
Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium 312
Transient supranuclear paresis of the abduction in viral encephalitis of the brainstem 312
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 308
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin? 285
Sindrome di Vogt-Koyanagi-Harada e gestazione 280
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 277
Demyelinating polyneuropathy in a case of anti-LGI1 encephalitis 275
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 273
A difficult case: sarcoidosis with CNS involvement or sarcoidosis associated with multiple sclerosis? 272
Postpartum relapses increase the risk of disability progression in multiple sclerosis: The role of disease modifying drugs 271
ANTIBODIES DIRECTED AGAINST THE MYELIN BASIC PROTEIN RECOGNISING AN EPITOPE OF CD64 AND THEIR USE AS IMMUNOSUPPRESSANT 268
Association of anti-GM1 antibodies but not of anti-cytomegalovirus, Campylobacter jejuni and Helicobacter pylori IgG, with a poor outcome in Guillain-Barré syndrome 266
Successful response of non-recovering Ramsay Hunt syndrome to intravenous high dose methylprednisolone 265
Impairment of vertical saccades from an acute pontine lesion in multiple sclerosis 264
Expression of tight junction and drug efflux transporter proteins in an in vitro model of human blood-brain barrier 259
Expression of preprotachykinin-A mRNA isoforms and substance P production in T lymphocytes of human healthy subjects 256
Circulating gp120 alters the blood-brain barrier permeability in HIV-1 gp120 transgenic mice 253
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery 253
Serum anti-brain endothelium antibodies and cognitive assessment in patients with Binswanger's encephalopathy 251
Anti-HTLV-I antibodies in the serum and CSF from amyotrophic lateral sclerosis patients: negative findings 248
Autoimmunitary changes in adrenoleukodystrophy and adrenomyeloneuropathy 248
Serum beta-2 microglobulin levels and cognitive function in chronic dialysis patients 244
Nimodipine confers clinical improvement in two models of experimental autoimmune encephalomyelitis 244
Symptomatic cranial neuralgias in multiple sclerosis: Clinical features and treatment 243
Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy 242
Adrenomyeloneurodystrophy with late cerebral involvement and evidence of a multiple autoimmune disorder 242
Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment 241
Clinical-radiologic heterogeneity of occipital neuralgiform pain as multiple sclerosis relapse 240
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 239
A novel highly selective cannabinoid CB2 agonist reduces in vitro growth and TGF-beta release of human glial cell tumors 239
Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis 235
Adrenoleukodystrophy: a genetic, clinical, biochemical and computed tomographic study of four patients in three different families 235
Cytokine production from peripheral mononuclear cells in 2 patients affected by adrenomyeloneuropathy 233
Behçet's disease: an unusual case with bilateral obliterating retinal panarteritis and ischemic optic atrophy 233
Clinical features of Sjogren’s syndrome in patients with multiple sclerosis 232
Lymphocyte activating factor activity in the serum and cerebrospinal fluid of patients with multiple sclerosis 231
Miller-Fisher syndrome following vaccination against influenza virus A/H1N1 in an AIDS patient 230
High frequency of psoriasis in relatives is associated with early onset in an Italian multiple sclerosis cohort 229
Serotonin levels and depression in patients with multiple sclerosis 228
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta 227
Early synthesis and correlation of serum anti-thyroid antibodies with clinical parameters in multiple sclerosis 226
The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C 224
Long time interval between multiple sclerosis onset and occurrence of primary Sjogren's syndrome in a woman treated with interferon-beta 220
Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy 216
VII Congress of the Italian Neuroimmunology Group 214
Idiopathic bilateral facial palsy: is a causative role of anti-GM1 ganglioside and herpes simplex type 1 possible? 213
High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients 209
Reply to :" Miller Fisher syndrome following vaccination" 209
L'endotelio cerebrale: ruolo nell'immunità 209
Impairment of human brain development: glycoconjugate and lipid changes in congenital athyroidism 208
Higher expression of BDNF receptor gp145trkB is associated with lower apoptosis intensity in T cell lines in multiple sclerosis 207
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 206
Increase of predominantly k-type light chains in the CSF of a case of subacute sclerosing panencephalitis treated with interferon 202
Registro toscano e sclerosi multipla: dati preliminari 202
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 202
Breastfeeding is not related to postpartum relapses in multiple sclerosis 200
Association of serum polyclonal anti-GM1 IgM and anti-neurofilament antibodies with CSF oligoclonal bands in a young with amyotrophic lateral sclerosis 199
Aspetti biologici dell'interleukina-1 199
Multiple sclerosis onset after antitetanus toxoid immunoglobulin prophylaxis 198
Development of cerebellar cells in neuron enriched cultures: cell surface proteins 197
Aggiornamenti sull'eziopatogenesi della Sclerosi multipla 197
The prevalence of pain in multiple sclerosis. A multicenter cross-sectional study 196
IL-6 detection in multiple sclerosis brain 195
Cerebrospinal fluid immunoglobulins and neurologic diseases [Immunoglobuline liquorali e malattie neurologiche] 194
Alcune evidenze per un possibile ruolo del sistema immunitario nella patogenesi della Sclerosi laterale amiotrofica 193
Congenital metachromatic leucodystrophy with severe and persistent muscular hypotonia [Leucodistrofia metacromatica congenita con grave e persistente ipotonia muscolare] 192
Supportive strategies to improve adherence to IFN β-1b in multiple sclerosis - Results of the βPlus observational cohort study 192
Cerebrospinal fluid markers of demyelination: MBP and anti-brain protein antibodies 192
Les glycoconjuguées de membranes dans la maladie de Creutzfeldt-Jakob 192
HIV-1 gp 120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance p 192
Enhanced secretion of substance P by cytokine-stimulated rat brain endothelium cultures 191
Acute transverse myelitis and hepatitis C virus 190
Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients 190
Stability of lysosomal enzyme activity in post-mortem rat brain 190
Neurochemical changes in Creutzfeldt-Jakob disease 190
Study of influence of sex and age on human normal serum lysosomal enzymes by using 4-methylumbelliferyl substrates 190
Brain glycosidases in Creutzfeldt-Jakob disease 188
Serum fractions from amyotrophic lateral sclerosis patients depress voltage-activated Ca2+ of rat cerebellar granule cells in culture 187
Meaningful improvement in walking performance after botulinum neurotoxin A (BoNT-A) in chronic spastic patients 187
null 186
Effect of aging on the heterosaccharide moiety of glycoproteins: study of concanavalin A-bound glycoproteins and glycosidases 185
Lessons from the "Euro-Lupus Cohort" 184
Certain surface properties of isolated and cultured cerebellar cells 184
Adult dementia in three siblings: ceroid-lipofuscinosis 184
Frequency of blood-retina and blood-brain barrier changes in multiple sclerosis 182
Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice 177
Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination 175
High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis 172
Established and emerging features of brain vessel inflammation 170
Detection of Borrelia burgdoferi DNA and complement attack complex deposits in the sural nerve of a patient with chronic polyneuropathy and tertiary Lyme disease 170
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis 170
Complement alterations in the CSF of patients with amyotrophic lateral sclerosis 167
Totale 23.833
Categoria #
all - tutte 73.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.014 0 0 54 100 47 43 76 53 63 166 143 269
2022/20232.309 138 129 280 308 245 456 56 183 235 133 104 42
2023/20241.380 63 44 116 50 73 332 426 46 12 39 51 128
2024/20252.890 73 163 238 157 397 141 69 142 240 115 309 846
2025/20266.227 567 1.081 622 596 1.031 241 703 186 172 269 118 641
2026/2027944 345 269 330 0 0 0 0 0 0 0 0 0
Totale 26.719